Pure Extracts Technologies Corp Ordinary Shares PRXTF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.00–0.04
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $630,540.78
- Volume/Avg
- 40,652 / 42,253
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.33
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Pure Extracts Technologies Corp is a plant-based extraction company. The company specializes in the processing of cannabis, hemp and functional mushrooms to produce oils and various derivative products. Also, the company is involved in white labelling activities as well as selling branded oil-based products. It has three operating segments, the extraction and processing of cannabis and hemp, the development and commercialization of functional wellness products including psychedelic medicinal products, and its head office.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 22
- Website
- https://www.pureextractscorp.com
Valuation
|
Metric
|
PRXTF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.33 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PRXTF
|
|---|---|
Quick Ratio | 0.08 |
Current Ratio | 0.37 |
Interest Coverage | −11.40 |
Quick Ratio
PRXTF
Profitability
|
Metric
|
PRXTF
|
|---|---|
Return on Assets (Normalized) | −65.51% |
Return on Equity (Normalized) | −239.14% |
Return on Invested Capital (Normalized) | −102.24% |
Return on Assets
PRXTF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Vsbycqxld | Zmzm | $73.0 Bil | |
MKKGY
| Merck KGaA ADR | Dhtnssghd | Fdwfwcn | $69.8 Bil | |
HLN
| Haleon PLC ADR | Wlvknrcg | Jsl | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Qsynjktk | Dxnyq | $14.6 Bil | |
VTRS
| Viatris Inc | Szdykscwk | Mttl | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jbmxzhz | Mgrlj | $12.6 Bil | |
CTLT
| Catalent Inc | Zwbdycdn | Wtcfcv | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Cqjypztsc | Bsrm | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Ckztqtfkk | Xqst | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Rssvkkyqj | Trglwm | $3.6 Bil |